Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
285 studies found for:    autism spectrum disorders OR autism OR pervasive developmental disorders OR PDD OR Kanner's syndrome OR child mental disorders OR asperger syndrome OR autistic OR developmental disabilities | Open Studies | NIH
Show Display Options
RSS Create an RSS feed from your search for:
autism spectrum disorders OR autism OR pervasive developmental disorders OR PDD OR Kanner's syndrome OR child mental disorders OR asperger syndrome OR autistic OR developmental disabilities | Open Studies | NIH
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Screening for Studies on Autism Spectrum Disorders
Condition: Autism Spectrum Disorders
Intervention:
2 Recruiting Adaptive Interventions for Minimally Verbal Children With ASD in the Community
Condition: Autism
Interventions: Behavioral: JASP-EMT;   Behavioral: DTT
3 Recruiting Cognitive Neuroscience of Autism Spectrum Disorders
Conditions: Asperger's Disorder;   Mental Retardation;   Children;   Adult;   Autism Spectrum Disorders
Intervention:
4 Recruiting Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD)
Condition: Children at Risk for ASD
Interventions: Behavioral: Baby JASPER;   Behavioral: Standard Baby Classroom
5 Recruiting Near Infrared Spectroscopy in Children With Autism and ADHD
Conditions: Attention Deficit Disorder With Hyperactivity;   Attention Deficit Disorder;   Attention Deficit Hyperactivity Disorder;   Autism;   Autism Spectrum Disorders
Intervention:
6 Recruiting Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders
Conditions: Neurological Disorder;   Autism
Intervention:
7 Recruiting A Salivary miRNA Diagnostic Test for Autism
Conditions: Autism Spectrum Disorder;   Developmental Delay
Interventions: Other: Salivary collection;   Other: Vineland Adaptive Behavior Scale-II Assessment;   Other: Medical history questionaire;   Other: Autism Diagnostic Observation Schedule -2nd edition (ADOS-2)
8 Recruiting Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels Of Repetitive Behavior
Condition: Autism
Interventions: Drug: Risperidone;   Drug: Placebo
9 Recruiting Changing Developmental Trajectories Through Early Treatment
Condition: Autism Spectrum Disorders
Interventions: Behavioral: PII with IES;   Behavioral: IES
10 Recruiting Pivotal Response Treatment Package for Young Children With Autism
Conditions: Autism Spectrum Disorder (ASD);   Autism
Intervention: Behavioral: Pivotal Response Treatment Package (PRT-P)
11 Recruiting Road to Discovery for Combination Probiotic BB-12 With LGG in Treating Autism Spectrum Disorder
Conditions: Autism;   Inflammation
Interventions: Drug: BB-12 with LGG;   Drug: Placebo
12 Recruiting The Role of Vasopressin in the Social Deficits of Autism
Condition: Autism Spectrum Disorders
Interventions: Drug: Vasopressin;   Drug: Placebo
13 Recruiting Schema, Emotion, and Behavior Therapy for Children
Condition: Autism Spectrum Disorder
Interventions: Behavioral: Individual Cognitive Behavioral Therapy;   Behavioral: Standard Community Treatment
14 Recruiting Gaming for Autism to Mold Executive Skills Project
Condition: Autism Spectrum Disorders
Intervention: Behavioral: Computerized executive control training
15 Recruiting Parent Language Intervention for Autism
Condition: Autism
Interventions: Behavioral: Responsive Intervention;   Behavioral: Directive Intervention
16 Recruiting Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors
Condition: Neoplasms
Intervention: Drug: Veliparib + VX-970 + Cisplatin
17 Recruiting Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma
Conditions: Stage III Hypopharyngeal Squamous Cell Carcinoma;   Stage III Laryngeal Squamous Cell Carcinoma;   Stage III Oral Cavity Squamous Cell Carcinoma;   Stage III Oropharyngeal Squamous Cell Carcinoma;   Stage IV Hypopharyngeal Squamous Cell Carcinoma;   Stage IV Laryngeal Squamous Cell Carcinoma;   Stage IV Oral Cavity Squamous Cell Carcinoma;   Stage IV Oropharyngeal Squamous Cell Carcinoma;   Stage IVA Hypopharyngeal Squamous Cell Carcinoma;   Stage IVA Laryngeal Squamous Cell Carcinoma;   Stage IVA Oral Cavity Squamous Cell Carcinoma;   Stage IVA Oropharyngeal Squamous Cell Carcinoma;   Stage IVB Hypopharyngeal Squamous Cell Carcinoma;   Stage IVB Laryngeal Squamous Cell Carcinoma;   Stage IVB Oral Cavity Squamous Cell Carcinoma;   Stage IVB Oropharyngeal Squamous Cell Carcinoma
Interventions: Drug: Cisplatin;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab
18 Recruiting VX-970, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced HPV-Negative Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Squamous Cell Carcinoma;   Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage III Oropharyngeal Squamous Cell Carcinoma;   Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage IVA Oropharyngeal Squamous Cell Carcinoma;   Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage IVB Oropharyngeal Squamous Cell Carcinoma;   Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage IVC Oropharyngeal Squamous Cell Carcinoma
Interventions: Drug: ATR Kinase Inhibitor VX-970;   Drug: Cisplatin;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Radiation: Radiation Therapy
19 Recruiting Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Conditions: BRCA1 Mutation Carrier;   BRCA2 Mutation Carrier;   Metastatic Pancreatic Adenocarcinoma;   PALB2 Gene Mutation;   Pancreatic Adenocarcinoma;   Recurrent Pancreatic Carcinoma;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Veliparib
20 Recruiting Cisplatin and Gemcitabine Hydrochloride With or Without ATR Kinase Inhibitor VX-970 in Treating Patients With Metastatic Urothelial Cancer
Conditions: Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter;   Stage IV Bladder Urothelial Carcinoma
Interventions: Drug: ATR Kinase Inhibitor VX-970;   Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.